Skip to main content
SpringerLink
Log in

Risk of death with ARB use higher in blinded vs unblinded trials

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Strauss M, Hall AS.A comparative meta-analysis of 42 blinded and 15 unblinded randomised controlled trials of angiotensin II AT1 receptor antagonist treatment in 149,601 pts with cardiovascular disease. 20th European Meeting on Hypertension: abstr. PP.24.465, 18 Jun 2010. Available from: URL: http://journals.lww.com/jhypertension/toc/2010/06001

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Risk of death with ARB use higher in blinded vs unblinded trials. React. Wkly. 1312, 2 (2010). https://doi.org/10.2165/00128415-201013120-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-201013120-00003

Keywords

Search

Navigation